Comparison of adjunctive use of aripiprazole with bupropion or selective serotonin reuptake inhibitors/serotonin–norepinephrine reuptake inhibitors: analysis of patients beginning adjunctive treatment in a 52-week, open-label study
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1756-0500
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Comparison of adjunctive use of aripiprazole with bupropion or selective serotonin reuptake inhibitors/serotonin–norepinephrine reuptake inhibitors: analysis of patients beginning adjunctive treatment in a 52-week, open-label study ; volume:7 ; number:1 ; day:18 ; month:7 ; year:2014 ; pages:1-11 ; date:12.2014
BMC Research Notes / Biomed Central; 7, Heft 1 (18.7.2014), 1-11, 12.2014
- Urheber
-
Clayton, Anita H.
Baker, Ross A.
Sheehan, John J.
Cain, Zachary J.
Forbes, Robert A.
Marler, Sabrina Vogel
Marcus, Ronald
Berman, Robert M.
Thase, Michael E.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/1756-0500-7-459
- URN
-
urn:nbn:de:101:1-2019102906531485332943
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:24 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Clayton, Anita H.
- Baker, Ross A.
- Sheehan, John J.
- Cain, Zachary J.
- Forbes, Robert A.
- Marler, Sabrina Vogel
- Marcus, Ronald
- Berman, Robert M.
- Thase, Michael E.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Risk of stress cardiomyopathy associated with selective serotonin reuptake inhibitors and serotonin and norepinephrine reuptake inhibitors: a real-world pharmacovigilance analysis
Serotonin syndrome triggered by postoperative administration of serotonin noradrenaline reuptake inhibitor (SNRI)
Prenatal exposure to serotonin reuptake inhibitors: a case report
Selective serotonin reuptake inhibitors induce cell death via the unfolded protein response
Selective Serotonin Reuptake Inhibitor Use in Pregnancy and Protective Mechanisms in Preeclampsia
Selective serotonin reuptake inhibitors: a new modality for the treatment of lymphoma/leukaemia?
Clinical and economic outcomes of adjunctive therapy with pregabalin or usual care in generalized anxiety disorder patients with partial response to selective serotonin reuptake inhibitors
Selective serotonin reuptake inhibitor use and breast cancer survival: a population-based cohort study
Selective serotonin re-uptake inhibitor sertraline inhibits bone healing in a calvarial defect model
The serotonin reuptake inhibitor Fluoxetine inhibits SARS-CoV-2 in human lung tissue
Serotonin reuptake inhibitors improve muscle stem cell function and muscle regeneration in male mice
Selective serotonin reuptake inhibitors regulate the interrelation between 5-HT and inflammation after myocardial infarction
Risk of stress cardiomyopathy associated with selective serotonin reuptake inhibitors and serotonin and norepinephrine reuptake inhibitors: a real-world pharmacovigilance analysis
Serotonin syndrome triggered by postoperative administration of serotonin noradrenaline reuptake inhibitor (SNRI)
Prenatal exposure to serotonin reuptake inhibitors: a case report
Selective serotonin reuptake inhibitors induce cell death via the unfolded protein response
Selective Serotonin Reuptake Inhibitor Use in Pregnancy and Protective Mechanisms in Preeclampsia
Selective serotonin reuptake inhibitors: a new modality for the treatment of lymphoma/leukaemia?
Clinical and economic outcomes of adjunctive therapy with pregabalin or usual care in generalized anxiety disorder patients with partial response to selective serotonin reuptake inhibitors
Selective serotonin reuptake inhibitor use and breast cancer survival: a population-based cohort study
Selective serotonin re-uptake inhibitor sertraline inhibits bone healing in a calvarial defect model
The serotonin reuptake inhibitor Fluoxetine inhibits SARS-CoV-2 in human lung tissue
Serotonin reuptake inhibitors improve muscle stem cell function and muscle regeneration in male mice
Selective serotonin reuptake inhibitors regulate the interrelation between 5-HT and inflammation after myocardial infarction
Risk of stress cardiomyopathy associated with selective serotonin reuptake inhibitors and serotonin and norepinephrine reuptake inhibitors: a real-world pharmacovigilance analysis
Serotonin syndrome triggered by postoperative administration of serotonin noradrenaline reuptake inhibitor (SNRI)
Prenatal exposure to serotonin reuptake inhibitors: a case report
Selective serotonin reuptake inhibitors induce cell death via the unfolded protein response
Selective Serotonin Reuptake Inhibitor Use in Pregnancy and Protective Mechanisms in Preeclampsia
Selective serotonin reuptake inhibitors: a new modality for the treatment of lymphoma/leukaemia?
Clinical and economic outcomes of adjunctive therapy with pregabalin or usual care in generalized anxiety disorder patients with partial response to selective serotonin reuptake inhibitors
Selective serotonin reuptake inhibitor use and breast cancer survival: a population-based cohort study
Selective serotonin re-uptake inhibitor sertraline inhibits bone healing in a calvarial defect model
The serotonin reuptake inhibitor Fluoxetine inhibits SARS-CoV-2 in human lung tissue
Serotonin reuptake inhibitors improve muscle stem cell function and muscle regeneration in male mice